1. 24P The predictive and prognostic role of single nucleotide gene variants in PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors. (December 2022) Authors: Boutros, A.; Carosio, R.; Campanella, D.; Spagnolo, F.; Banelli, B.; Morabito, A.; Pistillo, M.P.; Croce, E.; Cecchi, F.; Pronzato, P.; Queirolo, P.; Fontana, V.; Tanda, E.T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 63P Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis. (December 2022) Authors: A. Boutros, ; Tanda, E.T.; Croce, E.; Catalano, F.; Ceppi, M.; Bruzzone, M.; Cecchi, F.; Arecco, L.; Fraguglia, M.; Pronzato, P.; Del Mastro, L.; Lambertini, M.; Spagnolo, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗